Himadri Speciality Chemical

Quick check

The five things to look at first. Open one for more.

• DebtHigh safetyRated AA by ICRA.
• ResultsGrowingIn the Sep 2026 quarter, sales rose 58% and profit rose 31% from a year earlier.
• DilutionNo new sharesNo new shares issued in the last year, so existing shareholders' slices were not cut.
• PromotersPromoters buyingThe promoters (founders or parent) own 52%, up from 52% in Sep 2025.
• ValuationCheap vs its pastThe share trades at 31.4 times its yearly earnings (P/E), cheaper than 82% of the time in the last 5 years. Its usual P/E is about 24.

Exchange filings and their impact on the company.

• 16 Oct 2026Outcome of Board MeetingHigh impactVery positivePrice −8.3% on 19 Oct
  Record Q2 with 58% revenue jump and 31% profit growth, but margins and working capital stretched.

  Himadri Speciality Chemical reported strong Q2 FY27 consolidated results with revenue from operations at Rs 1,691.4 crore, up 58% from Rs 1,071 crore a year ago, and net profit at Rs 231.3 crore, up 31% year-on-year. For the half year, revenue was Rs 3,123.3 crore and net profit Rs 459.8 crore, but operating margin slipped to 17.9% in Q2 from 22.2% last year and borrowings rose to fund higher receivables. The growth momentum points to materially higher revenue and profit over the next year, though margins and working capital will need watching.

  Full analysisFiling
• 9 Oct 2026UpdatesLow impactNeutralPrice +0.2% on 12 Oct
  Allotted Rs 150 cr of 80-day commercial paper at 6.6% for short-term funding.

  Himadri Speciality Chemical allotted 3,000 units of commercial paper of Rs 5 lakh each aggregating to Rs 150 crore on 9 October 2026. The 80-day unsecured paper carries 6.60% p.a. discount, matures on 28 December 2026, and is listed on BSE. It is routine short-term funding with no material impact on long-term leverage or earnings.

  Full analysisFiling

Results dates and other board meetings. Full calendar

Compounded yearly rates over each period.